at onset | Group 0 (n=0) | Group I (n=28) | Group II (n=29) | Group III (n=38) | Group IV (n=69) | P-value | |
ICU mortality | - | 7% | 17% | 18% | 26% | 0.03 | |
All-cause hospital mortality | - | 39% | 38% | 29% | 36% | 0.73 | |
90-day mortality | - | 39% | 38% | 42% | 40.5% | 0.83 | |
VFD-28 | - | 22 [15-25] | 23 [7-25] | 22 [8-25] | 17 [0-24] | 0.09 | |
after 24 hours | Group 0 (n=20) | Group I (n=27) | Group II (n=15) | Group III (n=42) | Group IV (n=60) | P-value | |
ICU mortality | 0% | 7% | 20% | 12% | 37% | <0.0001 | |
All-cause hospital mortality | 10% | 33% | 27% | 38% | 45% | 0.0073 | |
90-day mortality | 20% | 30% | 33% | 45% | 50% | 0.0057 | |
VFD-28 | 27 [27-27] | 21 [11-25] | 20 [2-24] | 21 [13-24] | 11 [0-21] | <0.0001 |